- High-risk refractory or relapsed ALL in patients for whom transplantation is deemed indicated (primary induction failure or hypodiploidy, relapse occurring < 30 months from diagnosis, relapse after previous allogeneic hematopoietic stem cell transplant [allo-HSCT], relapse after 2nd remission)